Shares of X-Energy surged 10.1% to $20.98 on August 8, extending a blistering five-session run of nearly 29% from a July 31 close of $16.31. The catalyst: a definitive agreement with Centrus Energy for long-term supply of enriched uranium fuel — both standard and the higher-grade HALEU variety needed to power X-Energy's small modular reactors . For a company still years from generating reactor revenue, the deal addresses one of the sector's biggest question marks: where the fuel will come from.

  • The Fuel Bottleneck That Spooked Investors Is Getting Smaller. X-Energy's own SEC filings warned that its fuel subsidiary "will depend on the U.S. government for access to HALEU given the current inability to access global markets." This deal shifts part of that dependence to a commercial supplier. Centrus will produce the enriched uranium at its Ohio plant for delivery to X-Energy's fuel facility in Oak Ridge, Tennessee.

The contract includes prepayments from X-Energy to Centrus "under a phased approach to scale HALEU production." Those upfront cash commitments eat into X-Energy's $944 million liquidity cushion reported at the end of Q1 — a burn rate investors must watch closely.

  • 11.5 Gigawatts Sounds Impressive, but Most of It Remains Aspirational. X-Energy's pipeline comprises 144 reactors totaling about 11.5 GW , with projects underway with Dow, Amazon, and Centrica . Yet the company doesn't expect initial deliveries to reach mechanical completion until the early 2030s . The Centrus deal covers only "a portion" of initial fuel needs, not the full pipeline. That gap between ambition and locked-in supply keeps execution risk firmly on the table.

  • A Rapid-Fire Supply Chain Strategy Builds Credibility — Slowly. In just the past few months, X-Energy has stacked deals: a 10-year graphite supply agreement with SGL Carbon valued at over $100 million, an MOU with Japan's IHI for reactor components, and a letter of intent with Talen Energy for roughly 1 GW of deployment . Each agreement checks a box. None, however, substitutes for the regulatory approvals, construction milestones, and customer payments that will ultimately determine whether the stock — still trading 9% below its $23 IPO price — deserves a premium.

  • The Stock's Surge Reflects Hope, Not Revenue. Q1 revenue and grant income totaled $43.4 million against $109.5 million in operating expenses . X-Energy itself expects "to continue to incur operating losses for the foreseeable future." Investors are buying a narrative of nuclear revival, underwritten by Amazon and Dow commitments. The Centrus deal strengthens that narrative — but until reactors produce power, every rally remains a bet on execution.